ALBUQUERQUE (KRQE) – A group of scientists at the UNM Cancer Center have just discovered a new anti-inflammatory drug that acts against ovarian cancer.
The drug has already been approved and is proving to slow cancer growth and help women live longer after surgery. The drug, Ketorolac, ultimately helps control cellular growth and the spreading of active cancer cells.
The discovery of this drug could open up more opportunity in research of how to treat ovarian cancer. The scientists are planning a series of human clinical trials to better understand how Ketrolac works in women after ovarian cancer surgery.
Ovarian cancer has no symptoms. Often, it is discovered only after it has spread to other organs. Fewer than half of women diagnosed with ovarian cancer are still alive five years later.